Navigation Links
Wolters Kluwer Appoints Robert Becker as President and CEO Wolters Kluwer Health; and Stacey Caywood as President and CEO Wolters Kluwer Law & Business (U.S.)
Date:10/31/2008

AMSTERDAM, Netherlands, Oct. 31 /PRNewswire/ -- Wolters Kluwer, a market leading global information services and publishing company focused on professionals, today announced the appointment of Robert Becker to the position of President and CEO Wolters Kluwer Health effective November 1, 2008. Mr. Becker is currently CEO of Wolters Kluwer Law & Business. Stacey Caywood will be appointed President and CEO of Wolters Kluwer Law & Business (U.S.).

Mr. Becker (U.S., 1954) has extensive experience in the information industry and a track record of successful performance at Wolters Kluwer Law & Business, a unit of the Tax, Accounting & Legal division.

According to Nancy McKinstry, CEO and Chairman of the Executive Board of Wolters Kluwer, "Bob brings strong leadership skills and a track record of successful execution to this new role. Bob joined the company in 2003, and under his leadership the Law & Business unit has transformed from a traditional publisher to a world-class content and solutions provider. Our Health business today will greatly benefit from his capacities and experience in the industry."

Ms. McKinstry continued, "Our Health business has leading brands, deep content, advanced platforms and enormous growth potential, particularly as digital record keeping and information sharing gain greater acceptance in healthcare delivery. We have exceptional opportunities ahead of us. I believe Bob will do an excellent job of translating them into profitable growth at Wolters Kluwer Health."

Mr. Becker has been global CEO of Wolters Kluwer Law & Business since July 2003. Prior to joining Wolters Kluwer, he was CEO of Jupiter Media Metrix. His rich leadership experience in the global media and information services industry includes 13 years at the Thomson Corporation. Mr. Becker also ran a technology-based Internet start-up firm and spent nine years with PriceWaterhouse. Mr. Becker holds a Bachelor of Science in Accounting and Finance fro
'/>"/>

SOURCE Wolters Kluwer
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related medicine news :

1. Wolters Kluwer Health Introduces Formulary Facts(TM), a Formulary Analytics Tool that Sets the Standard for Accuracy and Ease-of-Use
2. Wolters Kluwer Health Appoints Susan Driscoll as Executive Vice President & General Manager of the Books Business of its Professional & Education Unit
3. Wolters Kluwer Health Appoints Scott Lubeck Vice President, Technology of its Professional & Education Unit
4. WorldHeart Appoints David Pellone Chief Financial Officer
5. Novo Nordisk Appoints New Leader of North American Business
6. Millstone Medical Outsourcing Appoints Operations Manager of New Memphis, TN, Facility
7. China Holdings Appoints Ronald Shon Chairman of Advisory Board to Its Wholly-Owned Subsidiary China Power, Inc.
8. Resonant Medical Appoints New Vice President of Global Sales
9. Response Biomedical appoints S. Wayne Kay Chief Executive Officer
10. Stem Cell Therapy Disappoints Against Rare Kidney Ailment
11. EPI-Q Opens East Coast Office and Appoints Vice President-Business Development

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2009)...A team of Kendall Hunt authors earned the 2009 Gif... recent National Association for Gifted Children&r...7, 2009. , Dubuque, IA (P...uthors earned the 2009 Gifted Child Quarterly Pape...tion for Gifted Children’s annual conference...
(Date:12/2/2009)...s Washington Post Highlights Dangers ,, ...f the Catholic bishops have their way, many medica... granted may be under threat. The pressure that t...ver healthcare reform has been widely reported. An...he likely impact if that pressure to influence hea...
(Date:12/2/2009)...d in birth defect that affects male urethra, resea...Day News) -- Male babies of women who use insect r...cy appear to be at increased risk for a birth defe...is birth defect, which affects about two of every ... the urethra, the tube that carries urine from the...
(Date:12/2/2009)...ike unlikely heroes in the battle against drug abu...already used to study dozens of human disease cou...fruit flies can be used as a simpler and more conv...caine and other drugs of abuse on the brain. Their...e , a new monthly journal. , Andrew Ewing and c...
(Date:12/2/2009)...MyCareTeam, Inc., a leading vendor of Internet-bas...ed the newest version of its software offering. T...ve heart failure and weight management capabilitie...features. , Acton, MA. ...ading vendor of Internet-based chronic disease man...
Breaking Medicine News(10 mins):Health News:Kendall Hunt Authors Earn NAGC “Paper of the Year” Award 2Health News:Everybody's Healthcare Is Threatened by Catholic Bishops' Interference 2Health News:MyCareTeam™ Significantly Extends Diabetes Offering to Include Management of Hypertension, Obesity, and Congestive Heart Failure 2
...sease are more likely to have a specific variant o...arried out tests on 500 men who had died suddenly,... found that, in men younger than 55, a gene varian... Men with HPA-2 Met have blood that is 'stickier' ...
...tain over-the-counter pain killers should carry wa...age. The comments follow a study by Danish re...hed in this week's British Medical Journal which s...records to identify a study group of pregnant wome...
...anufactured by Bayer Pharmaceuticals. Baycol, whic...statin group of drugs that lowers cholesterol by b...s of cholesterol in the body. Bayer Pharmaceu... a muscular side effect called rhabdomyolysis – de...
...iversity of north Carolina at Chapel Hill, state ...t genetic instructions into action. The U...ical site on a key enzyme that regulates productio...n DNA,is converted into functions critical for mai...
...ncer, a single raw clove of garlic can do wonders...Garlic is best known for staying off heart disease... A substance called diallyl disulfide in garlic is...de to rats and found it increased levels of the ca...
...a genetically engineered drug called NATRECOR to e... failure patients. Congestive heart failure is...gh blood to meet the needs of the body's other org...d Drug Administration approved an injection of Nat...
Other Medicine News:
(Date:12/2/2009)... Dec. 2 PDL BioPharma, I... has established the per share amount of the previ...1.67 per share. The dividend will be paid on Decem... as of the December 1, 2009 record date. NASDAQ ha...mount of the dividend at $1.67 per share of common...
(Date:12/2/2009)...ec. 2 Roche (SIX: RO, RO...tates Food & Drug Administration (FDA) approve...eic acid test, to screen source plasma in pools co..., called the cobas® TaqScreen MPX Test for us...n-vitro test for the simultaneous, direct detectio...
(Date:12/2/2009)...a, Dec. 2 /PRNewswire-Asia/ -- Simcere Pharmaceuti...R ), a leading pharmaceutical company,specializing...of branded,generic and proprietary pharmaceuticals...gsu Yanshen Biological Technology Stock Co., Ltd. ...l its products in order to conduct an,internal ins...
Breaking Medicine Technology:PDL BioPharma Announces December 15 Special Dividend Payment of $1.67 per Share 2PDL BioPharma Announces December 15 Special Dividend Payment of $1.67 per Share 3FDA Approves Use of Roche Test to Screen Source Plasma for HIV, Hepatitis B Virus and Hepatitis C Virus 2FDA Approves Use of Roche Test to Screen Source Plasma for HIV, Hepatitis B Virus and Hepatitis C Virus 3Simcere Pharmaceutical Group Announces Jiangsu Yanshen's Voluntary Suspension of Production 2Simcere Pharmaceutical Group Announces Jiangsu Yanshen's Voluntary Suspension of Production 3Rate of teen binge drinking cut more than 1 3 by prevention system 56343 1Rate of teen binge drinking cut more than 1 3 by prevention system 56343 2Rate of teen binge drinking cut more than 1 3 by prevention system 56343 3Even Mild Infections Hasten Decline With Alzheimers 56340 1Even Mild Infections Hasten Decline With Alzheimers 56340 2Even Mild Infections Hasten Decline With Alzheimers 56340 3Genomes reveal bacterial lifestyles 3A Research 9817 1Genomes reveal bacterial lifestyles 3A Research 9817 2
...INESS WIRE)--Jun 12, 2007 - Results from the,succe...Nasdaq:,OSCI) FACTIVE(R) (gemifloxacin mesylate) t...uired pneumonia of mild to moderate,severity (CAP)...-reviewed Journal of Antimicrobial Chemotherapy, c...om the Phase III clinical,trial comparing a five-d...
...SINESS WIRE)--Jun 12, 2007 - Proprietary Pulsed,El...y Ivivi,Technologies, Inc. (AMEX:II), improved neu...ain inflammation, researchers,reported today in a ...ociety (BEMS,http://www.bioelectromagnetics.org) ...s associated with neuron death that occurs in,Park...
Other Medicine Technology:July Issue of Journal of Antimicrobial Chemotherapy Highlights,Study of Factive Tablets for Five-Day Treatment of,Community-Acquired Pneumonia 2July Issue of Journal of Antimicrobial Chemotherapy Highlights,Study of Factive Tablets for Five-Day Treatment of,Community-Acquired Pneumonia 3July Issue of Journal of Antimicrobial Chemotherapy Highlights,Study of Factive Tablets for Five-Day Treatment of,Community-Acquired Pneumonia 4July Issue of Journal of Antimicrobial Chemotherapy Highlights,Study of Factive Tablets for Five-Day Treatment of,Community-Acquired Pneumonia 5Ivivi's PEMF Technology Significantly Improves Neuron Survival in,Parkinson's Disease Model, Study Finds 2Ivivi's PEMF Technology Significantly Improves Neuron Survival in,Parkinson's Disease Model, Study Finds 3
PocketPractitioner™ Office
Archimedes™
Prentice Hall Nurse's Drug Guide 2006
Physician's Drug Handbook, 10th Ed
Medicine Products: